Wayne State University
Wayne State University Theses

1-1-2016

Ambivalence Over Emotional Expression, Social
Constraints, And Trauma As Moderators Of
Emotional Awareness And Expression Training
And Relaxation Training For Individuals With
Irritable Bowel Syndrome
Hannah Holmes
Wayne State University,

Follow this and additional works at: https://digitalcommons.wayne.edu/oa_theses
Part of the Clinical Psychology Commons
Recommended Citation
Holmes, Hannah, "Ambivalence Over Emotional Expression, Social Constraints, And Trauma As Moderators Of Emotional Awareness
And Expression Training And Relaxation Training For Individuals With Irritable Bowel Syndrome" (2016). Wayne State University
Theses. 490.
https://digitalcommons.wayne.edu/oa_theses/490

This Open Access Thesis is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne
State University Theses by an authorized administrator of DigitalCommons@WayneState.

AMBIVALENCE OVER EMOTIONAL EXPRESSION, SOCIAL CONSTRAINTS, AND
TRAUMA AS MODERATORS OF EMOTIONAL AWARENESS AND EXPRESSION
TRAINING AND RELAXATION TRAINING FOR INDIVIDUALS WITH IRRITABLE
BOWEL SYNDROME
by
HANNAH HOLMES
THESIS
Submitted to the Graduate School
of Wayne State University,
Detroit, Michigan
in partial fulfillment of the requirements
for the degree of
MASTER OF ARTS
2016
MAJOR: PSYCHOLOGY (clinical)
Approved By:

________________________________________
Advisor
Date

ACKNOWLEDGEMENTS
I would like to thank my advisor, Dr. Mark Lumley, who has provided invaluable
mentorship and support throughout this project. I am grateful to Dr. Elyse Thakur for her
leadership on this project, as well as the many others in the Stress and Health lab (Jen Carty, Maisa
Ziadni, Heather Doherty, Nancy Lockhart) whose hard work and dedication to the implementation
of this study were indispensable to its success. Finally, I would like to thank my family and friends
for their kindness, patience, and support, which have been instrumental in bringing this thesis to
completion.

ii

TABLE OF CONTENTS
Acknowledgments ...........................................................................................................................ii
Chapter 1 – Introduction ..................................................................................................................1
Relaxation Training.............................................................................................................4
The Role of Emotional Awareness and Expression in IBS…………………….…………...6
Results from an RCT Comparing EAET and RT…………………………………………………8
Individual Differences in Response to IBS Treatment...........................................................9
Trauma…………………………………………………………………………………...10
Ambivalence over Emotional Expression………………………………………………...13
Social Constraints…………………………………………………………………..……14
Goal of This Study………………………………………………………………………..15
Chapter 2 – Method……………………………………………………………………………....17
Participants........................................................................................................................17
Procedures ........................................................................................................................18
Emotional Awareness and Expression Training.................................................................20
Relaxation Training……………………………………………………………….……..22
Waitlist Control………………………………………………………………...………...24
Primary Potential Moderator Measures…………………………………………………….....24
Secondary Potential Moderator Measures……………………………………………………..25
Health Outcome Measures…………………………………………………………………….....26
Statistical Analyses………………………………………………………………………………..27
Chapter 3 – Results ........................................................................................................................28
Trauma...............................................................................................................................28

iii

Ambivalence over Emotional Expression...........................................................................29
General Social Constraints…………………....................................................................30
Additional Analyses………………………………………………………………………31
Chapter 4 – Discussion ..................................................................................................................34
Trauma as a Moderator…………………………………………………………………..34
Ambivalence over Emotional Expression as a Moderator…………………………..……35
General Social Constraints as a Moderator……………………………………………...36
Additional Moderator Analyses…………………………………………………………..38
Limitations……………………………………………………………………………….39
Future Directions………………………………………………………………………...40
Implications………………………………………………………………………………42
Appendix: Tables & Figures………………………………………………………………….......43
References .....................................................................................................................................69
Abstract .........................................................................................................................................80
Autobiographical Statement..........................................................................................…….........82

iv

1
CHAPTER 1
INTRODUCTION
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by abdominal
pain or discomfort and features of disordered defecation (e.g., diarrhea, constipation; Rome III
Diagnostic Criteria, 2012). This syndrome is estimated to occur in approximately 10-15% of the
population (World Gastroenterology Organization, 2009) and affects women at a higher rate than
men (Lovell & Ford, 2012). Irritable bowel syndrome is considered to have a multifactorial
etiology, and should be viewed from a biopsychosocial perspective (Drossman, 1998; Halpert &
Drossman, 2005).
Various psychosocial factors have been shown to play a role in the development of IBS
and the severity of IBS symptoms (Drossman, 1999; Lea & Whorwell, 2003). Life stress is among
the most studied of these factors. Both chronic life stress (Bennett, 1998) and daily stressful events
and hassles (Dancey et al., 1998; Levy, Cain, Jarrett, & Heitempter, 1997) are positively related to
IBS symptoms. This relationship appears to be reciprocal, so that stress impacts the severity of
gastrointestinal (GI) symptoms, and GI symptoms contribute to stress (Blanchard et al., 2008).
Stress may induce changes in GI function, autonomic and neuroendocrine responses, and pain
modulation (Chang, 2011). Furthermore, there is evidence to suggest that stress contributes to
central sensitization, which refers to the hypersensitivity of the central nervous system (Yunus,
2008), which is exhibited by many individuals with IBS and other functional somatic syndromes
(Woolf, 2011; Zhou, Fillingim, Riley, Malarkey, & Verne, 2010). This relationship between stress
and physiological mechanisms exemplifies the biopsychosocial understanding of IBS that prevails
today.
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Other psychological, social, and personality variables are associated with IBS as well.
Research suggests that psychopathology plays a role in the development of IBS (Sykes, Blanchard,
Lackner, Keefer, & Krasner, 2003). In particular, depression and anxiety are strongly associated
with coexisting somatic symptoms in general (Kroenke, 2003) and IBS specifically. Anxiety and
depression have been shown to predict the subsequent onset of IBS (Koloski et al., 2012; Sykes,
Blanchard, Lackner, Keefer, & Krasner, 2003). Furthermore, functional gastrointestinal disorders,
which include IBS, are associated with the development of anxiety and depression at a later time,
indicating a bidirectional relationship between the gut and the brain (Koloski et al., 2012).
Similarly, worry is a factor in gastrointestinal symptom severity (Keefer et al., 2005) and pain
(Lackner & Quigley, 2005) in individuals with IBS. Catastrophizing appears to work in
conjunction with anxiety to maintain and/or exacerbate symptoms. Both catastrophizing and
somatization are associated with IBS severity, and one study showed that catastrophizing and
somatization were the mechanisms by which anxiety had an effect on IBS severity (van Tilburg,
Palsson, & Whitehead, 2013). Furthermore, catastrophizing has been shown to be the mechanism
by which worry is related to pain suffering (Lackner & Quigley, 2005).
The relationship between alexithymia, which refers to difficulty identifying or expressing
feelings, and GI symptoms is fairly well-established among functional GI disorders. Those with
functional gastrointestinal disorders are more alexithymic than those with inflammatory bowel
disease, which is an organic (autoimmune) gastrointestinal disorder (Porcelli, Taylor, Bagby, &
De Carne, 1999). In another study, alexithymia was shown to be a significant predictor of IBS and
symptom severity. The defectiveness/shame schema, which is related to alexithymia in that it is
thought to arise from fragility related to emotional deprivation, was also found to be a significant
predictor of IBS and symptom severity in the same study (Phillips, Wright, & Kent, 2013). Finally,
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social support may act as a buffer against each of these risk factors; those with more social support
tend to have lower IBS symptom severity and pain (Lackner et al., 2010).
Irritable bowel syndrome can be debilitating, greatly affecting the functioning and quality
of life of many patients (Corney & Stanton, 1990; Frank et al., 2002), and feasible, effective
treatments remain somewhat elusive. Because the mechanisms involved in the development of IBS
are uncertain, pharmacological treatments target symptoms rather than causes. Pharmacological
treatments include prokinetics for constipation, antispasmodics to reduce abdominal pain and
cramping, and opioid agents, 5-HT3 antagonists, and anticholinergic agents for diarrhea
(Grundmann & Yoon, 2010). Ford et al. (2014) conducted a systematic review of studies
comparing antidepressants, which are commonly prescribed for IBS, to placebo, and concluded
that antidepressants are effective for IBS on average. However, many people do not benefit; the
same review reported that of 592 patients assigned to antidepressant therapy, 260 (43.9%) reported
unimproved IBS symptoms (Ford et al., 2014). Furthermore, most patients who reported
improvement still had IBS symptoms.
Medical care costs for patients with IBS can be high (Levy et al., 2001; Longstreth et al.,
2003), which is problematic especially if these medical treatments are not helpful for some
patients. As many as 50% of individuals with IBS report having used complementary and
alternative medicine approaches (Hussain & Quigley, 2006), including herbal therapies, mindbody therapies, acupuncture, dietary changes, probiotics, and exercise. Current systematic reviews
provide conflicting findings, some reporting evidence-based support for these interventions, and
others indicating no support (Yoon, Grundmann, Koepp, & Farrell, 2011). Psychological
treatments for IBS, including cognitive behavioral therapy (CBT), relaxation training,
hypnotherapy, multicomponent psychological therapy, dynamic psychotherapy, mindfulness

4
meditation training, and stress management, have also been evaluated. Meta-analyses of
psychological treatments for IBS have shown them to be effective overall (Lackner, Mesmer,
Morley, Dowzer, & Hamilton, 2004; Ford et al., 2014). Relaxation training, which was used in the
present study, is discussed in detail next.
Relaxation Training
Relaxation training is an arousal-reducing treatment which involves teaching individuals
how to purposefully relax. Techniques such as progressive muscle relaxation, relaxed breathing,
and guided imagery are often used, and are thought to decrease stress, pain, and anxiety if
consistently practiced. Relaxation training is often a component of multicomponent treatments
such as CBT, both in practice and in research. For example, one recent study (Labus et al., 2013)
evaluated the efficacy of a brief psychoeducational intervention that consisted of education on a
biological mind-body disease model and emphasized self-efficacy and practical relaxation
techniques. The intervention was shown to be efficacious in reducing IBS symptom severity,
depression, visceral sensitivity, and catastrophizing, and improving quality of life and coping
skills. Although the direct effect of the relaxation component is unclear, this study illustrates how
relaxation training is often a key component of other effective treatments
Blanchard, Green, Scharff, and Schwarz-McMorris (1993) compared relaxation training
(composed primarily of progressive muscle relaxation) to regular GI-monitoring and found that
participants assigned to relaxation training showed significantly more improvement on a
composite measure of symptom reduction. Furthermore, 50% of the relaxation training group was
clinically improved at the end of treatment. In a study that compared four, 90-minute sessions of
relaxation training in small groups to a standard medical care control group, IBS symptom severity
was significantly reduced in the relaxation training group compared to the control group. This
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effect was seen immediately after the intervention and 6 and 12 months later, suggesting that
relaxation training has both short- and long-term benefits (Van der Veek, Van Rood, & Masclee,
2007).
There is some evidence for the effectiveness of other variations of relaxation training as
well. Relaxation Response Meditation (RRM) consists of assuming a comfortable position in a
quiet environment and focusing on the word “one” while maintaining a passive attitude. In a study
that compared RRM to a waitlist control, 67% of the RRM group was clinically improved after
treatment (Keefer & Blanchard, 2001). These effects remained at the 12-week and 1-year followup time points (Keefer & Blanchard, 2002). This study showed promising preliminary results, but
a major limitation was the very small total sample size (N=13). Furthermore, while flatulence and
belching, diarrhea, constipation, and bloating were improved, there was no change in pain or
abdominal tenderness. Functional relaxation is an intervention used in the treatment of various
psychosomatic disorders. It aims to positively stimulate the autonomic nervous system and
facilitate proprioceptive awareness by performing diminutive movements of small joints during
relaxed expiration, and focusing on the perceived differences of body feelings triggered by the
movements. In one study, functional relaxation was compared to an enhanced medical care
condition which consisted of treatment as usual plus two counseling interviews, and functional
relaxation was found to be significantly superior to enhanced medical care in terms of reducing
bodily and psychological impairment (Lahmann et al., 2010).
In conclusion, there is some support for relaxation training’s usefulness in treating IBS
symptoms, but relaxation training does not help everyone, and it is unclear who might benefit the
most from relaxation training. Toner (2005) pointed out that many studies of CBT, which often
include relaxation training, have methodological weaknesses such as insufficient sample sizes and
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control conditions. A final consideration related to relaxation training is that it is primarily aimed
toward minimizing negative emotions and arousal. Although this may be helpful for some patients
with IBS, there may be others who would benefit from becoming aware of, experiencing, and
expressing their emotions, rather than directly attenuating them—a topic to which I now turn.
The Role of Emotional Awareness and Expression in IBS
There are established literatures showing that emotional expression and disclosure of the
facts and one’s thoughts and feelings about stressful experiences can be beneficial to health. These
findings are consistent with research that shows that emotions are strongly connected with the
body, and the experience and/or suppression of emotions induces physiological and subjective
changes. In both individuals with IBS and healthy controls, everyday words with emotional content
(e.g., angry, sad, anxious) induce changes in rectal tone, suggesting that emotional states modify
intestinal reactivity (Blomhoff, Spetalen, Jacobsen, Vatn, & Malt, 2000). Furthermore,
suppressing negative emotions has been shown to result in negative outcomes. For example, anger
suppression has been implicated in the increase of pain in both healthy (Quartana, Bounds, Yoon,
Goodin, & Burns, 2010) and chronic pain (Burns, Bruehl, & Quartana, 2006) samples.
This link between emotions and physical symptoms appears to be of particular importance
in those with chronic pain conditions. It has been suggested that clinical interventions aimed at
reversing anger suppression—that is, facilitating anger expression—may reduce chronic pain
severity (Burns, Quartana, & Bruehl, 2008). Given the high levels of trait and suppressed anger
found in patients with IBS compared to those with an autoimmune GI condition, Crohn’s disease
(Beesley, 2010), such interventions may be particularly helpful to those with IBS. In a similar vein,
Abbass (2005) proposed that emotion-focused interviewing could be used in medical settings to
help diagnose somatization, such that if experiencing anger or some other emotion in a clinical
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setting causes an immediate change in symptoms, then the patient likely is experiencing
somatization.
The effectiveness of self-disclosure and emotional expression has been evaluated primarily
by studying written emotional disclosure (expressive writing) in a wide variety of contexts and
populations. Pennebaker and Beall (1986) first studied the effect of writing about traumatic
experiences in a college student population and found that writing resulted in short-term increases
in physiological arousal, but long-term decreases in health problems—especially for those who
wrote not only about the trauma, but also about their feelings associated with it. Writing about
stressful or traumatic events, compared to writing about neutral events has also been shown to
improve symptom severity in people with asthma or rheumatoid arthritis (Smyth, Stone, Hurewitz,
& Kaell, 1999) and reduce pain and fatigue and increase psychological well-being in patients with
fibromyalgia (Broderick, Junghaenel, & Schwartz, 2005).
Written disclosure has been studied among those with functional gastrointestinal
conditions as well. Written self-disclosure has been shown to be more effective than standard
medical care in reducing activity-limiting GI pain and health care utilization among youth with
functional abdominal pain, which is often a precursor of IBS (Wallander, Madan-Swain, Klapow,
& Saeed, 2011). Among individuals with IBS, those who participated in online expressive writing
showed a significant decrease in IBS severity and improved disease-related cognition compared
to a non-writing group (Halpert, Rybin, & Doros, 2010). In this study, those who reported higher
disclosure of emotions were more likely to show improvement in coping three months later.
Overall, experimental disclosure has been found to have a beneficial effect on participants’
psychological health, physiological functioning, reported health, and general functioning
(Frattaroli, 2006). However, the benefit of disclosure in specific pain populations is less clear, and
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appears to be rather modest (Lumley, Sklar, & Carty, 2012). Notably, the vast majority of research
to date focuses on written emotional disclosure, as opposed to oral self-disclosure to others in one’s
life or with a clinician who can guide emotional expression. Less research has evaluated the effects
of non-written emotional expression and self-disclosure, which may be more effective than written
emotional expression and self-disclosure alone for individuals with chronic pain disorders such as
IBS.
In a prior study, our laboratory developed and tested an intervention encouraging the
awareness and expression of anger (Anger Awareness and Expression Training) for people with
chronic headaches (Slavin-Spenny, Lumley, Thakur, Nevedal, & Hijazi, 2013). Furthermore, our
research group is testing a similar emotional processing intervention which goes beyond anger to
include other emotions, particularly connecting, vulnerable emotions, in patients with
fibromyalgia. Following this line of research, Emotional Awareness and Expression Training
(EAET) is a guided, non-written emotional processing intervention that encourages the awareness
and expression of emotions, ranging from anger and dominance to vulnerability and connection.
It will be important to evaluate whether such an intervention is are beneficial for patients with IBS
and other chronic pain, and this study sought to contribute to that end.
Results from an RCT Comparing EAET and RT
Main effects from the RCT from which the current study is taken, which are in preparation
for publication by Thakur et al. (2016), showed that both EAET and RT produced lower IBS
symptom severity and anxiety and higher quality of life at 4-week follow-up compared to TAU,
and these gains were maintained at 12-week follow-up, although TAU improved in symptom
severity and anxiety as well, which eliminated any group differences on these two outcomes
(Thakur, 2016).

These findings are consistent with past research: emotional interventions,
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relaxation training, and other approaches appear to create positive change in IBS, but effect sizes
tend to be modest, indicating that there are likely individual differences that moderate the effects
(Lumley, 2004). Therefore, although it has been shown that both interventions are beneficial for
individuals with IBS, more research is needed in order to determine who benefits most from each
intervention.
Individual Differences in Response to IBS Treatment
Research has shown various factors that predict outcomes for a variety of treatments. For
example, the presence of any Axis I disorder is associated with poorer outcomes from cognitive
behavioral treatment of IBS (Blanchard, 1992). Among those with functional gastrointestinal
disorders, having alexithymia or depression predicts poorer outcomes of combination treatments
that consist of medications, diet modifications, and psychological counseling or brief
psychotherapy; alexithymia emerged as the strongest predictor among the three (Porcelli et al.,
2003). In a study of a psychoeducational group intervention for patients with IBS, those with low
to moderate baseline quality of life showed greater improvement in symptom severity and quality
of life compared to those with higher quality of life (Labus et al., 2013). Other variables, such as
trauma history, emotional ambivalence, and social constraints may also play a role IBS onset and
severity as well as treatment outcomes, and these literatures will be reviewed later.
Although some studies have evaluated predictors of IBS treatment, fewer have examined
moderators of IBS treatments. Whereas predictors are baseline variables that relate to treatment
outcomes regardless of which treatment, moderator variables predict treatment outcomes
differently for different treatments, or for a treatment versus control condition. In a meta-analysis
of experimental disclosure, Frattaroli (2006) identified several moderators of outcome. Physical
health problems, a history of trauma or stressors, disclosing at home rather than in a controlled
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setting, greater privacy, greater number of disclosure sessions, length of disclosure sessions,
detailed and specific disclosure instructions, and disclosure of events that had yet to be fully
processed predicted greater overall effects of disclosure relative to control. Frattaroli emphasized
that because the best way to test for moderators is to examine them in a single study, rather than
across studies, as she did in her meta-analysis; thus it is best to consider the moderators she
identified as a starting point for future testing.
Lumley (2004) developed a model of who benefits from emotional disclosure. According
to this model, individuals are more likely to benefit from emotional disclosure when they have had
stressful experiences, can consciously acknowledge negative affect, are able to identify and
differentiate feelings, are motivated to disclose and value disclosure, are inhibited or ambivalent
about disclosing, or exist in an environment that discourages disclosure. This model serves as a
framework from which to consider potential moderators of the effects of interventions that
encourage emotional expression. Three proposed moderators of the effects of emotional awareness
and expression training are discussed in the following sections.
Trauma
The connection between traumatic experiences and IBS symptoms is well-established and
widely recognized. In particular, patients with IBS have a greater prevalence of childhood and
lifetime sexual abuse and trauma compared to patients with inflammatory bowel disease (Beesley,
2010; Jemelka & Russo, 1993; Ross, 2005) and pain-free control groups (Roelofs & Spinhoven,
2007). Physical and sexual trauma was also found to be independently associated with an elevated
risk of IBS among women veterans (White et al., 2010). The association between IBS and trauma
extends beyond sexual abuse to a wide range of early adverse life events, including general trauma
and physical and emotional abuse (Ali et al., 2000; Bradford et al., 2012; Roelofs & Spinhoven,
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2007). Given the increased prevalence of trauma and abuse among patients with IBS, it is not
surprising that post-traumatic stress disorder is common in patients with IBS and be positively
associated with the severity of IBS symptoms (Irwin, Falsetti, Lydiard, & Ballenger, 1996).
Several mechanisms have been proposed in regards to the how traumatic events increase a
person’s likelihood of developing IBS. Traumatic events may predispose an individual to
psychological distress, which would in turn predispose them to exaggerated reactions to stress
which would manifest as symptoms of IBS and hypervigilance toward GI symptoms (Chitkara,
van Tilburg, Blois-Martin, & Whitehead, 2008). It has also been suggested that other psychological
factors, including neuroticism, may partly explain the relationship between abuse and IBS (Talley,
Boyce, & Jones, 1998). Or, it may be the case that the relationship between trauma and IBS
develops via psychophysiological mechanisms. O’Mahoney et al. (2009) found that early life
stress induced changes across the brain-gut axis that could contribute to the susceptibility to
develop stress-related disorders such as IBS in adulthood. Trauma may contribute to central
sensitization (Drossman, 2010) or sensitization of intestinal visceral afferents (Chitkara et al.,
2008). Abuse underlies hyperarousal and hypersensitivity, which underlie both post-traumatic
stress disorder (PTSD) and IBS—which often co-occur (Drossman, 2010). Hyperresponsiveness
of the HPA axis to visceral stressors is related to a history of early life adverse events; therefore,
trauma may contribute indirectly to IBS by increasing HPA axis hyperresponsiveness (Videlock
et al., 2009).
Taken together, there is more than sufficient evidence to suggest that many individuals
with IBS have a trauma history. In considering what treatments will be most effective for
individuals with IBS, it can be helpful to look to the psychotherapy treatment literature for posttraumatic stress disorder (PTSD), because both populations share trauma histories as a common
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factor. Because individuals with traumatic histories tend to avoid thoughts and feelings associated
with their trauma, which they view as threatening, treatment should work toward reducing the
avoidance of negative emotions associated with the traumatic events. Foa and Kozak’s (1991)
exposure therapy for PTSD aims to do this by exposing individuals to negative emotions and
memories associated with the traumatic event in session. In-session exposure leads to emotional
processing and fear reduction by activating the fear memory, leading temporarily to physiological
arousal, and incorporating new cognitive and affective information about that fear memory (Foa
& Kozak, 1986). It is reasonable to consider emotional exposure treatments to be potentially
beneficial for individuals with IBS, given their higher rate of traumatic experiences.
Alternatively, emotion-reducing interventions such as relaxation training attempt to
alleviate symptoms by directly decreasing physiological responses to stress and down-regulating
or avoiding unpleasant or threatening emotions. It has been proposed that relaxation training may
reduce hyperarousal symptoms in PTSD patients, thereby reducing distress about and avoidance
of trauma-related stimuli, leading to therapeutic exposure even without formal exposure exercises
(Taylor et al., 2003). Relaxation training has been shown to be moderately effective in reducing
PTSD symptom severity, yet still less effective than exposure therapy (Marks, Lovell, Noshirvani,
Livanou, & Thrasher, 1998; Taylor et al., 2003).
In sum, exposure therapy is currently the most effective treatment for PTSD. Therefore,
individuals with IBS who have experienced traumatic events, which likely remain unprocessed
and unresolved, may benefit from an intervention that encourages the full experience of unresolved
emotions or conflicts related to the past trauma. Following this logic, such interventions will be of
little benefit for those with IBS who have not experienced traumatic events. One such intervention
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is EAET, for which a central component of treatment is encouraging the disclosure of suppressed
or hidden experiences and the identification, experiencing, and expression of associated emotions.
Ambivalence over Emotional Expression
Ambivalence over emotional expression refers to an individual’s ambivalence, or
conflicted feelings, about expressing his or her emotions. To date, no studies have examined
ambivalence over emotional expression among patients with IBS, but some studies have examined
related variables that have implications for this construct. Individuals with IBS tend to have higher
anxiety in relationships and lower self-esteem than those with inflammatory bowel disease, which
may lead to more conflicted feelings regarding expressing one’s emotions, especially to a friend
or family member (Bengtsoon, 2013). Bevan (2009) examined communication apprehension and
topic avoidance among individuals with IBS, and found that higher levels of communication
apprehension were found among individuals with IBS than those without it. Communication
apprehension was significantly correlated with IBS abdominal pain severity and frequency,
number of physician visits, and days spent in bed. Topic avoidance, which is defined as the
deliberate decision not to share information about a specific topic with close relational partners,
was reported more among those with IBS than those without it. Topic avoidance was positively
correlated with abdominal difficulty and number of doctor visits, and was a significant predictor
of abdominal difficulty. Furthermore, Ali et al. (2000) found that women with IBS scored higher
than women with inflammatory bowel disease on measures of self-silencing, which refers to
silencing certain thoughts, feelings, and actions in an attempt to create and maintain safe, intimate
relationships. Together, these findings indicate that ambivalence over emotional expression may
be prevalent among individuals with IBS and may exacerbate IBS symptoms.
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Because the self-silencing and topic avoidance that may result from ambivalence over
emotional expression have been shown to be related to IBS symptom severity and frequency,
reversing such patterns in individuals with IBS may help to reduce pain and discomfort. If in fact
ambivalence over emotional expression increases IBS symptom severity and frequency, and
reducing ambivalence may reverse or reduce these symptoms, we may expect that those with more
ambivalence would benefit more than those with less ambivalence, from treatments that encourage
emotional expression, compared to treatments that do not. In one study, ambivalence over
emotional expression was tested as a treatment moderator among women with chronic pelvic pain
who participated in an emotional disclosure intervention. Women with ambivalence over
emotional expression showed health improvements after the disclosure, whereas those with
ambivalence in the control condition showed a worsening of symptoms. This effect was
independent of the effect of negative affect on outcomes (Norman, Lumley, Dooley, & Diamond,
2004). This is good preliminary evidence that individuals with IBS who have ambivalence over
emotional expression will benefit from EAET.
Social Constraints
Social constraints are experienced “whenever we are compelled by others to regulate,
restrict, or modify our thoughts, actions, or feelings” (Lepore & Revenson, 2007, p. 313). No
research has yet explored the relationship between IBS and the construct of social constraints.
Perhaps the nearest construct is perceived social support, because those who do not feel supported
by their loved ones likely feel more constrained in the expression of their thoughts and feelings.
Social constraints can be conceived as a potential moderator of EAET outcomes in much
the same way as ambivalence over emotional expression. Those who are high in ambivalence over
emotional expression are likely not to express their feelings because they feel unsure and
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conflicted; those who are high in social constraints are likely not to express their feelings because
they feel pressured by others not to, in order to keep the peace. In both instances, an intervention
aimed toward facilitating emotional awareness and expression will likely be helpful.
Goal of This Study
The goal of this study was to examine which patients with IBS improve the most from
engaging in Emotional Awareness and Expression Training, relative to a conceptually opposite
intervention—relaxation training—and to no intervention. Childhood trauma, ambivalence over
emotional expression, and social constraints were examined as potential moderators of health
outcomes of EAET relative to the other two. Data for these analyses were taken from a randomized
controlled trial that examined the effects of EAET on overall improvement in symptoms,
psychological functioning, IBS symptom severity, and quality of life in patients with IBS.
Hypotheses
This study examined four hypotheses regarding the impact of three primary potential
moderators and three secondary potential moderators on health outcomes of EAET.
1. It was hypothesized that childhood traumatic events would moderate the effects of EAET
on health outcomes, such that those with more childhood traumatic events would have
greater improvements in health outcomes following EAET compared to both RT and
waitlist control.
2. It was hypothesized that ambivalence over emotional expression would moderate the
effects of EAET on health outcomes, such that those high in ambivalence over emotional
expression would have greater improvement in health outcomes following EAET
compared to RT and waitlist control.
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3. It was hypothesized that social constraints would moderate the effects of EAET on health
outcomes, such that those high in social constraints would have greater improvements in
health outcomes following EAET compared to RT and waitlist control.
4. It was hypothesized that three additional emotion-related variables – impact of events
(PTSD symptomatology), emotional approach coping, and alexithymia – would moderate
health outcomes following EAET compared to RT and waitlist control. Because these
analyses were exploratory, no specific hypotheses regarding directionality were made.
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CHAPTER 2
METHODS
Participants
Participants were 106 men and women over the age of 18 who had a physician-provided
diagnosis of irritable bowel syndrome (IBS) and/or who fulfilled all Rome-III criteria for IBS as
determined by our interview. Prospective participants were recruited from the larger community
as well as the university community to ensure a representative sample. Recruitment methods
included advertisements on the university pipeline, newspaper advertisements, fliers on campus
and in the community, and brochures and fliers at doctor’s offices, particularly those of
collaborating gastroenterologists. SONA, an online tool used by the Psychology Department to
screen students to participate in psychological research, was also used to identify students who had
IBS. We invited those students to participate in the study by contacting them via phone and/or
email.
Individuals who expressed interest by contacting the lab via email or phone were asked to
participate in a phone screening to verify their interest and eligibility to participate. First,
respondents were told about the study over the phone. If they remained interested, they were then
asked more detailed screening questions to determine whether or not they were eligible to
participate. To be eligible to participate, individuals must have reported that they had a diagnosis
of IBS and met the Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders,
specifically for IBS (Rome III Diagnostic Criteria, 2012). That is, they must have reported that
they had recurrent abdominal pain or discomfort, or a change in stool frequency or form, at least
three days per month for the last three months. They must also have reported having pain and
discomfort at least two days per week at the time of screening. Individuals who reported having
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post-infectious IBS, organic gastrointestinal diseases (e.g., inflammatory bowel disease including
Crohn’s disease and ulcerative colitis), immunodeficiency, a current psychotic disorder or bipolar
disorder, drug or alcohol dependence within the past two years, inability to communicate in
English, and/or participation in another clinical research trial for IBS were excluded.
Procedures
Individuals who met study criteria and were interested in participating were invited to the
laboratory to review the study procedures and provide written, informed consent. One of the study
therapists was assigned, based on her availability, to do this in-person work with each participant.
The participants also signed a release of their medical records so we could send a diagnostic
confirmation form to their primary care physician or gastroenterologist, which we asked to be
faxed back. We proceeded, however, based on patient’s self-reported diagnosis and used the
physician confirmation if available.
Participants then filled out several baseline questionnaires, assessing their IBS health and
functioning, psychological distress, and quality of life. They also completed the various potential
moderator measures at the same time. Participants entered the data using a web-based computer
system (Qualtrics). After the baseline questionnaires were complete, the therapist consulted a
randomization scheme to determine to which of the three intervention conditions the participant
was assigned. Randomization was then conducted in advance using the website,
randomization.com. Randomization was stratified by therapist and participant gender and
conducted in randomized blocks of three and six, so that the three conditions had equal proportions
of men and women and equal sample sizes after each block, and therapists worked with equal
numbers of men and women in each treatment condition. All randomization envelopes were
created in advance and sealed prior to baseline.
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Participants assigned to either of the two active interventions (EAET or RT) began their
first session immediately following their baseline assessment. Sessions were conducted at the
Wayne State Stress and Health lab and at various external locations that are part of Wayne State
(i.e., Oakland Center and Macomb Center). After the first visit, participants were scheduled to
return in one week for the second session and the week after that for their third session. Following
the third session, participants were asked to return to the laboratory two weeks later to fill out
follow-up questionnaires under supervision. Participants were then scheduled to return in 8 weeks
for their second follow-up visit. For both follow-ups, participants were given the option of
completing the measures from home using their own computer, if they preferred. Participants who
were in the waitlist control group completed follow-up questionnaires 4 and 12 weeks after
baseline (the equivalent time points to the two follow-up assessments for the active treatment
conditions), and were given the opportunity to participate in the intervention of their choice (either
RT or EAET) after the 12-week assessment. Participants were paid $20 for completing each of the
three assessment sessions (or up to $60 total). Intervention sessions were provided for free, and
participants were not compensated for the intervention sessions.
All three sessions for both interventions were conducted in an individualized format and
ran for 50 minutes, once per week. All intervention sessions were run by one of five female
therapists who were either graduate students in clinical psychology or a master’s level nurse. All
therapists were trained and supervised by a licensed clinical psychologist, and sessions were audio
recorded to facilitate supervision and fidelity checks. Sessions were conducted in a private room.
At the beginning and end of each session, patients completed a brief measure of their mood and
symptoms. At the end of each session, homework was provided so that participants could practice
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the skills learned in session. Regardless of condition, all participants were instructed to maintain
their usual care (i.e., pharmacological, dietary, or behavioral interventions) throughout the study.
Emotional Awareness and Expression Training
Emotional awareness and expression training (EAET) is an emotional processing
intervention. It is based on the principle that emotional suppression can lead to chronic
overarousal, symptoms including pain, and a dysregulated brain-gut neuroenteric system. The goal
of the intervention is to help patients reduce stress by: a) having them learn about connections
between their stressful life experiences and physical symptoms; b) teaching them to identify,
experience, and express their emotions related to these stressful situations; and c) encouraging
them to engage in healthy emotional and interpersonal behaviors in their daily lives, including
assertive and genuine communication. Ultimately, this intervention is intended to reduce IBS
symptoms by promoting cognitive and affective changes that improve an individual’s ability to
experience, express, and resolve their emotions and relate to others. Over the course of the three
sessions, patients first had a life history interview, which helped them connect their IBS to their
life experiences. Subsequently, the therapist conducted experiential exercises to help patients
engage with their avoided feelings, behaviors, memories, and relationships. Finally, patients were
encouraged to communicate more genuinely in their relationships. The three EAET sessions are
as follows:
Session One. A rationale for treatment was given, and the relationship between stress and
IBS was explored. The therapist focused on the role that emotional avoidance plays in the
relationship between stress and health. Next, participants were given a life history interview to
learn about their life experiences, particularly those that have been stressful and that continued to
be unresolved. To help participants recognize how life stress and emotional processes had
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contributed to their IBS, the therapist created a detailed timeline of the participant’s experiences
during the interview. The therapist also pointed out indicators of emotional avoidance and
explained how this perpetuates both stress and symptoms. At the end of the session, the therapist
and participant discussed the participant’s timeline and reaction to the interview. A writing
exercise that asked participants to express thoughts and feelings about conflicted relationships in
the form of unsent letters was given as homework.
Session Two. The therapist and participant reviewed the homework assignment and
discussed what stressors the participant identified and wrote about. Barriers to homework were
explored. After that, the therapist discussed the importance of expressing emotions. The participant
learned that emotional suppression can cause stress, which can exacerbate pain and alter bowel
functioning. They also learned that expression of certain emotions (e.g., anger, sadness, intimacy)
is often avoided because of fear or potential rejection by others. The bulk of the session involved
experiential exercises in which the therapist encouraged the participant to experience and express
emotions relevant to their stressful relationships, particularly those written about during the week.
These exercises also encouraged patients to experience affect in their bodies, and then
communicate these emotions directly, out loud, with voice, face, tone, and physical expression.
The therapist took a balanced stance that is both supportive but also directive to facilitate this
process. After this exercise, the therapist encouraged the participant to reflect on their experience.
Participants were assigned a homework assignment that asked them to monitor their emotional
avoidance and suppression in relationships, and asked them what they would ideally communicate.
Session Three. The final session began by discussing the participant’s homework. Barriers
to homework were explored. The therapist then reviewed what the participant learned in the
previous session, and the participant engaged in more emotional expression during interactive,
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experiential exercises. The bulk of the session was devoted to helping the patient learn how to
honestly and directly communicate feelings to others in an adaptive, responsible manner. For
example, assertive communication and the expression of care or love was examined and taught.
The participant practiced such honest communication during role-plays in session. At the end of
the session, there was a discussion of what the participant learned throughout the intervention. The
participant also generated goals for the future and discussed how they could continue to implement
emotional expression and assertive communication skills into their everyday lives.
Relaxation Training
Relaxation training (RT) is a stress-management treatment for IBS. It is an arousal
reduction approach, which is conceptually the opposite of EAET. It is based on the premise that
long-term stress elevates physiological arousal, exacerbates pain, and dysregulates communication
between the brain and the gut. The goal of RT is to reduce physiological arousal, thereby
attenuating symptoms. To facilitate this process, participants were taught different relaxation
training skills (e.g., progressive muscle relaxation, applied relaxation, and guided imagery).
During each session, participants were guided through the relaxation exercise. They also learned
variations of the techniques (e.g., relaxation mini-practices), so they could integrate them into their
everyday lives. In the end, these exercises minimized IBS symptoms by instigating cognitive and
behavioral changes that influence how one responds to stressors. The three RT sessions were as
follows:
Session One. A rationale for treatment was emphasized that stress causes arousal, which
increases symptoms, and that the goal of this technique is to directly reduce arousal. In addition,
the relationship between stress and IBS was discussed. After discussing these ideas, the therapist
guided the participant through a 20-minute relaxation exercise, Progressive Muscle Relaxation
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(PMR; Jacobson, 1938). The therapist demonstrated how to do the exercise, and then the
participant practiced. Following the exercise, the participant and the therapist discussed the
participant’s reaction to PMR. Then, for a homework assignment, the therapist asked participants
to listen to an audio recording (on CD or mp3) once per day that guided them through a PMR
practice.
Session Two. At the beginning of the session, the homework assignment was discussed.
The participant and therapist discussed how often the participant listened to the audio recording,
and evaluated how helpful it was at helping them relax. Barriers to practice were also explored.
After that, the therapist introduced the participant to the concept of applied relaxation, and guided
him or her through a 30-60 second relaxed breathing exercise (a “mini-practice”). Next, the
therapist taught the participant a 20-minute relaxed breathing technique. Following this exercise,
the therapist and participant discussed the participant’s reactions to this technique, and explored
how much the participant liked this exercise compared to PMR. For homework, the participant
was asked to practice this technique or PMR daily.
Session Three. This session followed a similar format to Session two. First, homework was
discussed and barriers to practice were explored. After that, the therapist taught the participant a
20-minute guided imagery relaxation exercise. Following the exercise, the therapist and participant
discussed the participant’s reactions to this exercise, and explored how much the participant liked
this exercise compared to the other relaxation training techniques. At the end of the session, the
participant described their experience with relaxation training in general and reflected on their
ability to manage stress. The final portion of the session was devoted to goal setting, where the
participant described how they will incorporate relaxation training into their daily routine in the
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future. The therapist encouraged the participant to continue to use the audio recordings to help
them reach their goals.
Waitlist Control
After baseline and during the intervention phase of this study, participants in the waitlist
control condition engaged in only standard medical care. After completing the 4- and 12-week
follow-up assessments, participants in the waitlist control condition were given the opportunity to
participate in RT or EAET. Both interventions were described in detail, and then participants
indicated which one they preferred. Sessions were scheduled with a therapist and began
immediately or shortly after their final assessment.
Primary Potential Moderator Measures
Early Trauma Inventory Self-Report Short Form (ETISR-SF; Bremner, Bolus, & Mayer,
2007). On this 27-item questionnaire, participants are asked to answer “yes” or “no” to a series of
questions related to trauma experiences before the age of 18. The questions are grouped into four
parts: General Traumas (e.g., “Were you ever exposed to a life-threatening natural disaster?”),
Physical Punishment (e.g., “Were you ever slapped or kicked?”), Emotional Abuse (“Were you
often put down or ridiculed?”), and Sexual Events (e.g., “Did you ever experience someone
rubbing their genitals against you?”). Items endorsed as “yes” were added together to yield a total
score, and higher total scores indicate more traumatic experiences.
Ambivalence over Emotional Expressiveness Questionnaire (AEQ; King & Emmons,
1990). This 14-item scale is used to rate participants’ ambivalence over expressing emotion.
Participants are asked to read each statement related to their goals and conflicts in regard to
emotional expression (e.g., “Often I’d like to show others how I feel, but something seems to hold
me back”) and indicate how frequently they have felt or experienced each one. Items are rated on
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a scale of 1 (“I have never felt like this”) to 5 (“I feel like this a lot”). Items are then averaged, and
higher mean scores indicate greater ambivalence over emotional expressiveness. This scale had
high internal consistency (α = .88).
General Social Constraints Scale (Lepore & Ituarte, 1999). This 15-item scale asks
participants to report how often friends or family members respond to them in such a way that
suggested the participant should conceal, avoid, or minimize sharing problems or concerns. (e.g.,
“How often in the past month have your friends or family members changed the subject when you
tried to discuss your problems?”). All items are rated on a scale of 1 (“never”) to 4 (“often”). Items
are then totaled, and higher mean scores indicate more social constraints. This scale had high
internal consistency (α = .91).
Secondary Potential Moderator Measures
Three additional emotion-related variables were also explored as potential moderators.
The Impact of Events Scale-Revised (IES-R; Weiss & Marmar, 1996) is a 22-item self-report scale
used to measure post-traumatic stress symptomatology. All items are rated on a scale of 0 (“not
at all”) to 4 (“extremely”). Responses on three subscales (Intrusion, Avoidance, and Hyperarousal)
were averaged to create mean subscale scores, and then the three subscales were summed to create
a total score, with higher scores indicating greater PTSD symptomatology. This scale had high
internal consistency (α = .91). Emotional approach coping (EAC) refers to the extent to which an
individual uses emotional expression and processing to cope with stress (Stanton, Kirk, Cameron,
& Danoff-Burg, 2000). All items are rated on a scale of 1 (“I don’t do this at all”) to 4 (“I do this
a lot”). Responses were averaged to create a mean scale score, with higher scores indicating a
stronger tendency toward using emotional expression and processing to cope with stress. This scale
had high internal consistency (α = .88). The 20-item Toronto Alexithymia Scale (TAS-20; Bagby,
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Parker, & Taylor, 1994) is a self-report scale that measures alexithymia, which refers to difficulty
identifying and describing feelings. All items are rated on a scale of 1 (“strongly disagree”) to 5
(“strongly agree”). Participants’ responses on all items were averaged to create a mean scale score,
with higher scores indicating more alexithymia. This scale had high internal consistency (α = .77).
Health Outcome Measures
McGill Pain Questionnaire (Melzack, 1975). The McGill Pain Questionnaire is a 23-item
self-report measure of pain. Participants were asked to report the quality and intensity of their pain
by rating the intensity of different types of pain (i.e., “aching,” “sharp,” “suffocating”) on a 1-10
scale. In this study, we averaged participants’ ratings to create a Total Pain score. This scale had
high internal consistency (α = .90).
IBS Symptom Severity Scale (IBS-SSS; Francis, Morris, & Whorwell, 1997). The IBS-SSS
consists of five questions measured on a 0-100 numerical rating scale. These questions assess the
severity and frequency of abdominal pain, the severity of abdominal distention, dissatisfaction
with bowel habits, and interference with quality of life over the last 10 days. All five items were
summed to create a total IBS symptom severity score (range: 0 – 500). A higher score indicates
greater symptom severity. This scale has an internal consistency of α = .46.
Irritable Bowel Syndrome-Quality of Life (IBS – QOL; Patrick, Drossman, Frederick,
Dicesare, & Puder, 1998). This 34-item scale assesses how IBS impacts participants’ quality of
life across several domains, including mood, activities, body image, health worry, social reaction,
sexuality, and relationships. Participants are asked to report how they generally feel by indicating
their level of agreement with each item on a scale of 1 (“not at all”) to 5 (“a great deal”). A total
score was obtained by summing all items, with higher scores indicating poorer quality of life. This
scale has an internal consistency of α = .95.
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Brief Symptom Inventory (Derogatis & Melisaratos, 1983). This 53-item scale assesses a
range of symptoms and general psychological distress. For each item participants rate their
discomfort over the past 2 weeks on a 5-point scale that ranges from 0 (“not at all”) to 4
(“extremely”). In this study, the Depression (α = .84), Anxiety (α = .78), and Interpersonal
Sensitivity (α = .85) subscales were analyzed.
Clinical Global Impressions (CGI) Improvement Scale – IBS version (Klein, 1999).
Participants were asked to compare their symptoms of abdominal discomfort or pain and bowel
symptoms before entering the study to those during the past week, on a 1 (“substantially
improved”) to 7 (“substantially worse”) scale. This measure was given only at the 4-week and 12week follow-up time points, but not at baseline.
Statistical Analyses
After conducting standard data cleaning procedures, SPSS version 22 was used to compute
descriptive statistics and bivariate correlations. Before testing the study’s hypotheses, missing
outcome data was replaced by carrying the last value forward (i.e., missing 4-week follow-up
scores were replaced with the same participant’s baseline scores, and missing 12-week follow-up
scores were replaced with 4-week follow-up scores). Then, change scores from baseline to each
follow-up timepoint were calculated; that is, baseline scores of each outcome measure were
subtracted from scores at 4-week and 12-week follow-ups. Thus, changes in health outcome
variables at 4-week follow-up and 12-week follow-up served as the dependent variables. The
PROCESS macro (Hayes, 2013) was used to conduct moderation analysis (MODEL 1). To test for
significance of effects, we obtained 95% bias-corrected bootstrapped confidence intervals based
on 1,000 bootstrapped samples.
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CHAPTER 3
RESULTS
Analyses of baseline data indicated that the three conditions were comparable on age,
gender, ethnicity, marital status, duration of symptoms (Table 1), and baseline levels of outcome
data (Table 2). See Table 3 for means, standard deviations and ranges of the potential moderators,
and the correlations among them. Table 4 provides means, standard deviations, and ranges for
outcome variables. Overall, moderators were moderately to highly correlated in the expected
directions. Trauma, ambivalence over emotional expression, general social constraints, impact of
events, and alexithymia all were positively correlated with one another (r = .17 to .60), but
emotional approach coping was negatively correlated with these moderators (r = -.13 to -.61). This
is to be expected, given that emotional approach coping measures an adaptive form of coping, and
the other moderators are measures of harmful events and negative emotional processes. Please see
Tables 5-10 for all correlations between moderators and changes in outcome measures at followup for each of the three treatment conditions.
Trauma
To test the hypothesis that participants with more childhood traumatic events would have
greater improvements in health outcomes following EAET compared to RT and waitlist control,
moderation analyses were conducted. This hypothesis was not supported. Baseline trauma
moderated the effect of treatment group (RT vs. WLC; RT vs. EAET) on changes in anxiety at the
12-week follow-up. This moderation effect was significant for RT vs. WLC (b = -.05, t(100) = 2.05, 95% CI [-.10, -001], p = .04) and marginal for RT vs. EAET (b = -.05, t(100) = -1.96, 95%
CI [-.09, .001], p = .05). Specifically, trauma weakly predicted improvement in anxiety from
baseline to 12-week follow-up after RT (r = -0.21) compared to less improvement in anxiety at
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12-week follow-up after WLC (r = .27) and EAET (r = .26; see Figure 1). See Table 5 for
correlations and significance for each condition.
Ambivalence over Emotional Expression
To test the hypothesis that those high in ambivalence over emotional expression would
have greater improvement in health outcomes following EAET compared to RT and WLC,
moderational analyses were conducted. This hypothesis was not supported. Ambivalence over
emotional expression moderated the effect of treatment group (RT vs. WLC) on depression at the
4-week follow-up (b = -.34, t(100) = -2.01, 95% CI [-.68, -.00], p = .047), such that ambivalence
significantly predicted improvement in depression from baseline to 4-week follow-up after RT (r
= -.35) compared to less improvement in depression after WLC (r = .08; see figure 2).
Ambivalence also significantly moderated the effects of treatment group (RT vs. WLC) on
interpersonal sensitivity at the 4-week follow-up (b = -.50, t(5, 90) = -2.14, 95% CI [-.97, -.04], p
= .04) and marginally so at the 12-week follow-up (b = -.45, t(5, 86) = -1.76, 95% CI [-.95, .06],
p = .08).

Specifically, ambivalence significantly predicted improvement in interpersonal

sensitivity from baseline to 4-week follow-up (r = -.37) after RT, compared to a very small
relationship between ambivalence and worsened interpersonal sensitivity (r = .07) after WLC (see
Figure 3). At 12-week follow-up, ambivalence predicted improvement in interpersonal sensitivity
12-weeks after RT (r = -.35) compared to no relationship after WLC (r = .02; see Figure 6).
Additionally, ambivalence marginally moderated the effects of treatment group (RT vs.
EAET, b = -.79, t(100) = -1.82, 95% CI [-1.66, .07], p = .07; RT vs. WLC, b = -.76, t(100) = -1.93,
95% CI [-1.55, .02], p = .06) and McGill total pain at the 12-week follow-up. Higher ambivalence
at baseline significantly predicted improvement in total pain from baseline to 4-week follow-up
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after RT (r = -.37), compared to no relationship after WLC (r = .06) and EAET (r = .05; see Figure
5).
Finally, ambivalence over emotional expression marginally moderated the effects of
treatment group (RT vs. EAET) on anxiety at the 12-week follow-up (b = -.30, t(100) = -1.75, 95%
CI [-.64, .04], p = .08), such that baseline ambivalence predicted improvement in anxiety from
baseline to 12-week follow-up after RT (r = -.20) compared to less improvement after EAET (r =
.23; see Figure 6). See Table 4 for correlations and significance for each condition.
General Social Constraints
To test the hypothesis that those high in social constraints would have greater
improvements in health outcomes following EAET compared to RT and waitlist control,
moderation analyses were conducted. This hypothesis was partially supported. Social constraints
moderated the effects of treatment group (RT vs. EAET, b = -.04, t(100) = .01, 95% CI [-.06, .01], p < .01; RT vs. WLC, b = -.05, t(100) = -3.69, 95% CI [-.08, -.02], p < .001) on anxiety at
12-week follow-up. Specifically, higher social constraints significantly predicted improvement in
anxiety from baseline to 12-week follow-up after RT (r = -.42), compared to less improvement
following EAET (r = .20) and WLC (r = .41; see Figure 7).
Social constraints also moderated the effects of treatment group (RT vs. EAET, (b = -.07,
t(100) = -1.66, 95% CI [-.15, .01], p = .0998); RT vs. WLC, b = -.14, t(100) = -3.07, 95% CI [-.24,
-.05], p = .003); EAET vs. WLC, b = .08, t(100) = 1.79, 95% CI [-.01, .16], p = .08) on 4-week
IBS symptom severity. This moderating effect was significant for RT vs. WLC, and marginally
significant for RT vs. EAET and EAET vs. WLC. Specifically, higher baseline social constraints
significantly predicted improvement in symptom severity from baseline to 4-week following RT
(r = -.36) compared to less improvement after WLC (r = .36). Social constraints significantly
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predicted improvement in IBS symptom severity following RT (r = -.36) compared to no
relationship after EAET (r = -.01). Higher baseline social constraints significantly predicted
improvement in symptom severity after WLC (r = .36), compared to no relationship with
improvements in symptom severity from baseline to 4-week follow-up after EAET (r = -.01; see
Figure 8).
Similarly, social constraints moderated the effects of treatment group (RT vs. WLC, b = .03, t(100) = -2.50, 95% CI [-.05, -.001], p = .01; EAET vs. WLC, b = 02, t(100) = 1.94, 95% CI
[-.001, .04], p = .055) on IBS-related quality of life at 4-week follow-up. This moderating effect
was significant for RT vs. WLC, and marginally significant for EAET vs. WLC. Specifically,
baseline social constraints significantly predicted improved IBS-related quality of life after RT (r
= -.37) compared to less improvement after WLC (r = .28). Social constraints also predicted
improvement in IBS-related quality of life after EAET (r = -.22) compared to less improvement
after WLC (r = .28; see Figure 9).
Finally, social constraints marginally moderated the effects of treatment group (RT
vs. WLC) on interpersonal sensitivity at 12-week follow-up (b = -.05, t(100) = -1.89, 95% CI [.10, .003], p = .06), such that baseline social constraints predicted improvement in interpersonal
sensitivity from baseline to 12-week follow-up after RT (r = -.25) compared to less improvement
after WLC (r = .18; see Figure 10). See Table 7 for correlations and significance for each
condition.
Additional Analyses
Additional emotion-related variables were tested as moderators using exploratory
moderation analyses.
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Impact of Events. Impact of events (i.e., PTSD symptomatology following trauma)
emerged as a moderator of the effects of treatment group (RT vs. WLC, b = -.33, t(100) = -1.99,
95% CI [-.66, -.01], p =.049; EAET vs. WLC, b = .30, t(100) = 1.87, 95% CI [-.02, .62], p = .07)
on total pain at 4-week follow-up. Specifically, higher baseline PTSD symptoms predicted
improvement in total pain from baseline to 4-week follow-up after RT (r = -.19) compared to less
improvement after WLC (r = .33). Additionally, baseline PTSD symptomatology predicted
improvement in total pain from baseline to 4-week follow-up after EAET (r = -.20) compared to
an association with less improvement after WLC (r = .33; see Figure 11).
PTSD symptoms also moderated the effects of treatment group (EAET vs. WLC) on IBSrelated quality of life (b = .10, t(100) = 1.91, 95% CI [-.004, .20], p = .06) and interpersonal
sensitivity (b = .17, t(100) = 1.69, 95% CI [-.03, .37], p = .09) at 4-week follow-up. Baseline
PTSD symptoms predicted improvements in IBS-related quality of life from baseline to 4-weeks
after EAET (r = -.25) compared to less improvement in quality of life following WLC (r = .33;
see Figure 12). Baseline PTSD symptoms also predicted improvements in interpersonal sensitivity
from baseline to 4-weeks following EAET (r = -.30) compared to less improvement after WLC (r
= .20; see Figure 13). See Table 8 for correlations and significance for each condition.
Emotional Approach Coping. Emotional approach coping moderated the effects of
treatment group (RT vs. WLC, b = -.48, t(100) = -2.73, 95% CI [-.83, -.13], p < .001; EAET vs.
WLC, b = -.31, t(100) = -1.69, 95% CI [-.68, .06], p = .09) on depression at 12-week follow-up.
This relationship was significant for RT vs. WLC, and marginally significant for EAET vs. WLC.
Baseline emotional approach coping significantly predicted improvement in depression from
baseline to 12-week follow-up after RT (r = -.34) compared to less improvement after WLC (r =
.27). Baseline emotional approach coping also predicted improvement in depression at 12-week
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follow-up after EAET (r = -.15) compared to less improvement in depression following WLC (r
= .27; see Figure 14).
Emotional approach to coping also significantly moderated the effects of treatment group
(RT vs. EAET) on participants’ rating of overall improvement in IBS symptoms (b = .26, t(100) =
2.17, 95% CI [.02, .50], p =.03), such that emotional approach coping predicted participant report
of overall improvement in IBS symptoms from baseline to 4-week follow-up after RT (r = .23),
compared to less improvement after EAET (r = -.27; see Figure 15). See Table 9 for correlations
and significance for each condition.
Toronto Alexithymia Scale. Alexithymia significantly moderated the effects of treatment
group (EAET vs. RT) on overall improvement in IBS symptoms as reported by participants (b = 5.04, t(100) = -2.24, CI [-9.49, -.58), p = .03), such that alexithymia at baseline predicted
improvement in IBS symptoms from baseline to 4-week follow-up after RT (r = -.28) compared
to less improvement following EAET (r = .23; see Figure 16). See Table 10 for correlations and
significance for each condition.
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CHAPTER 4
DISCUSSION
Effect sizes for psychological treatments for IBS are modest, indicating that there may be
subsets of patients who benefit differentially from certain interventions over others. The present
study examined whether psychological and emotional factors moderate the effects of treatment
group on health outcomes after two psychological interventions.

Specifically, trauma,

ambivalence over emotional expression, and general social constraints were examined to see
whether they differentially predict improvements in health after Emotional Awareness and
Expression Training (EAET), Relaxation Training (RT), and a Waitlist Control (WLC) condition.
Findings from the study indicate that, overall, the hypothesized and exploratory moderators
moderate the effects of treatment group on health outcomes for RT compared to WLC, but not
EAET compared to RT or WLC as hypothesized. Specifically, although both interventions (EAET
and RT) appeared to result in improved health outcomes at 1- and 12-week follow-up (Thakur et
al., 2016), it seems that RT was especially helpful for certain individuals, which may indicate that
EAET is more helpful to a greater number of patients with IBS while RT is differentially helpful
for certain groups. These findings will be discussed in further detail below.
Trauma as a Moderator
Results did not support the hypothesis that participants with more childhood traumatic
events would have greater improvements in health outcomes following EAET compared to RT
and WLC. Among participants who had more childhood traumatic events, those in the RT group
had more improvement in anxiety at 12-week follow-up compared to those in WLC or EAET. It
is possible that those with greater amounts of childhood trauma had more physiological
hyperarousal associated with anxiety, which was reduced by the relaxation techniques used in the
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RT condition. This finding was surprising, because it contradicts previous findings that indicate
that a history of trauma or stressors predicts greater overall effects of disclosure relative to control
(Frattaroli, 2006). It also does not support Lumley’s (2004) model of who would benefit from
emotional disclosure, which posits that those who have had stressful experiences would benefit
from disclosing emotions. It is possible that participants with more or less trauma than the amount
experienced by those in our sample would, in fact, benefit from disclosure. Further, it may be a
result of the brief (i.e., 3-session) course of treatment, which may have unearthed difficult and
painful emotions for those with a great deal of trauma, without the opportunity to continue
exploring and resolving these emotions with the same therapist longer-term.
Ambivalence over Emotional Expression as a Moderator
Again, the hypothesis that those high in ambivalence over emotional expression would
have greater improvement in health outcomes following EAET compared to RT and WLC was not
supported. Rather, the two findings suggest moderation of the effects of RT, but not EAET. Those
with high ambivalence showed greater reductions in depression at 4-week follow-up and
interpersonal sensitivity at 1- and 12-week follow-up after RT, compared to WLC. Additionally,
there were several marginal findings: those with higher ambivalence at baseline had greater
reductions in total pain following RT compared to both EAET and RT, and those with higher
ambivalence showed greater decreases in anxiety at 12-week follow-up after RT compared to
EAET and greater decreases in interpersonal sensitivity at 12-week after RT compared to WLC.
Overall, these findings indicate that individuals with high ambivalence over emotional
expression do better on multiple health outcomes after RT compared to WLC and EAET. These
findings were most prominent in regards to psychological health outcomes (i.e., depression,
anxiety, and interpersonal sensitivity) compared to pain outcomes. Ambivalence over emotional
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expression had previously been tested as a moderator of a treatment for chronic pain in only one
other study (Norman et al., 2004), which found that ambivalence over emotional expression
moderated health outcomes, such that participants with ambivalence benefited from disclosure,
whereas those with ambivalence in the control condition showed worsening of symptoms. One
hypothesis as to why individuals in our study who had greater ambivalence showed improved
outcomes following RT vs. WLC, but not EAET vs. RT, is that people with greater ambivalence
may be more anxious, and thus benefit more from a treatment (i.e., RT) aimed toward reducing
anxiety. It is also possible that highly ambivalent people may find an intervention such as RT that
does not require addressing their emotions to be more comfortable, desirable, or “fitting,” given
their personality, and thus respond well to it. Alternatively, those with low ambivalence did less
well after RT, indicating that perhaps these individuals would prefer to address emotional issues
related to their stress, but were not able to do so in RT.
General Social Constraints as a Moderator
The hypothesis that those high in social constraints would have greater improvements in
health outcomes following EAET compared to RT and waitlist control was partially supported.
Overall, social constraints moderated health outcomes following RT compared to WLC, with one
additional finding showing that social constraints moderated IBS-quality of life following EAET
compared to WLC. Social constraints moderated the effects of RT on IBS quality of life at 4-week
follow-up compared to WLC and anxiety at 12-week follow-up compared to both EAET and WLC,
such that individuals high in social constraints showed greater improvement in quality of life at 4week compared to WLC and greater reduction in anxiety at 12-week follow-up compared to both
EAET and WLC. Social constraints also moderated the effects of RT on IBS symptom severity at
4-week follow-up and interpersonal sensitivity at 12-week follow-up, such that those with high
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constraints showed greater improvement on both of these outcomes compared to WLC, but both
of these findings were marginal. The one exception to the pattern of social constraints moderating
the effects of RT but not EAET was IBS-related quality of life, and this finding was marginally
significant. Social constraints moderated IBS-related quality of life, such that those with high
social constraints showed more improved IBS-related quality of life following EAET compared to
WLC.
These findings about social constraints mirror those related to trauma and ambivalence
over emotional expression: social constraints appears to moderate the effects of RT, but not EAET.
It was unclear how social constraints would moderate the effects of these treatment interventions,
because social constraints had never been examined as a moderator, yet these findings contradicted
the theoretical expectation that those who feel less able to share thoughts and feelings with others
may especially benefit from an emotional disclosure intervention. Similar to the findings with
ambivalence over emotional expression, it is possible that social constraints is a proxy for anxiety,
and thus those with high social constraints differentially benefit from an intervention (RT) that
aims to reduce anxiety compared to their less socially constrained counterparts.
The significant correlation between social constraints and ambivalence over emotional
expression (r = .41, see Table 1) also points to another possibility: that people high in social
constraints and ambivalence have in common a discomfort with, lack of readiness, fear, or
reluctance to engage in emotionally expressive interventions. Although we hypothesized that these
individuals would do better in interventions aimed at increasing emotional expression, it could be
the case that people high in these constraints prefer RT and, in fact, do well with it, whereas those
low in these constructs, who prefer or see the value in engaging emotions and disclosing emotions,
do less well with RT because they want or need to address emotions. However, this explanation
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of why people high in social constraints do well in RT compared to their less socially constrained
counterparts does not explain why, conversely, people high in social constraints do not do more
poorly in EAET compared to people low in social constraints. It is possible that EAET is
conducted in such a manner that the therapist adjusts the level of intensity as needed to suit the
personality of the patient.
Additional Moderation Analyses
Overall, results from the additional moderation analyses reveal similar findings as our
primary hypotheses: impact of events (PTSD symptomatology), emotional approach coping, and
alexithymia all moderate the effects of RT, but not EAET or WLC, on outcomes. One notable
exception is with impact of events. Impact of events moderated effects of both RT and EAET,
such that those with higher baseline PTSD symptoms showed more improvement in pain at 4week following both RT and EAET compared to WLC. Additionally, those with higher baseline
PTSD symptoms showed greater improvement in IBS-related quality of life and interpersonal
sensitivity following EAET compared to WLC. This may suggest that, for those who have been
more negatively and persistently affected by trauma, receiving either type of treatment is especially
beneficial compared to receiving no treatment at all. This may be because IES is an indicator of
psychopathology (i.e., PTSD) as opposed to other moderators included in this study, which
measure variations in non-pathological emotion and personality variables. Thus, those with higher
levels of psychopathology differentially benefit from receiving any type of therapy.
Emotional approach coping moderated treatment effects in a similar way: overall, RT was
differentially beneficial in terms of depression and overall improvement outcomes for people high
in emotional approach coping. Interestingly, emotional approach coping also moderated the
effects of EAET on depression, such that those higher in emotional approach coping received more
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benefit in terms of improved depression at 12-week follow-up after EAET, compared to WLC.
These findings somewhat contradict the hypothesis that those who show interest in and readiness
for emotional engagement and expression do best with EAET, because these participants seemed
to better with both treatment groups. This provides some evidence that perhaps individuals high
in emotional engagement have better therapy outcomes overall.
Finally, alexithymia was found to moderate the effects of treatment group on overall
improvement in IBS symptoms at 4-week follow-up, such that those with higher alexithymia
received differential benefit from RT compared to less benefit from EAET. This finding is
consistent with findings regarding general social constraints and ambivalence over emotional
expression, lending more support to the hypothesis that those who, for various reasons, prefer not
to or cannot engage with emotional content and expression may prefer and benefit more from RT
compared to EAET.
Limitations
One limitation of this study is the small sample size (namely, less than 40 participants in
each treatment condition). These analyses had many marginally significant findings, which may
be a result of the small sample sizes, and may have been clarified with a greater number of
participants.

Furthermore, participants in this sample were relatively heterogeneous, and

demographics such as race and gender and disease characteristics such as duration of diagnosis
and disease severity may also play a role in which individuals improve from which treatments,
although these were not examined in this study. Moreover, such heterogeneity on these other
characteristics likely increases the challenge of identifying other, psychological moderators, which
can become “lost” in the substantial variance in the participants.
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As with other treatment intervention studies, the findings in this study apply only to the
treatments used in this study (i.e., EAET and RT). This is true not only of the content of the
treatments, but also their length and modality. Of note is that each intervention was conducted
one-on-one and was relatively brief (i.e., three 50-minute sessions). This does not necessarily
mirror other treatment settings, and thus findings are only generalizable to a brief course of
treatment in an individual format. Additionally, findings are only generalizable to individuals
with IBS; individuals with other chronic pain conditions may show different responses to the
treatments used in this study.
An additional limitation of this study is the overlap among several of the emotion-related
variables. It can be speculated based on the high correlations (see Table 1) and similar moderating
effects that variables such as ambivalence over emotional expression, general social constraints,
and alexithymia all tap into the same construct: reluctance or inability to engage with and express
emotions. Furthermore, moderators were tested on multiple outcomes and were found to be
significant across varying outcomes (rather than one or two consistent outcomes), which may
convolute the interpretation of our findings. We also tested several moderators, increasing the
possibility of a Type I error. Finally, although most moderator and outcome measures had high
reliability coefficients, the IBS symptom severity measure showed weak reliability (α = .46), which
may partially explain why only one moderator predicted outcomes on this measure.
Future Directions
Future studies should examine other potential moderators of EAET and RT, so that we can
continue to clarify which patients are best suited to different treatments. Such moderators could
include demographic factors or other psychological or emotional variables, such as readiness to
change. Based on the findings in the current study, it can be hypothesized that those with a high
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readiness to change, and further, readiness to engage in emotional engagement and expression,
may differentially benefit from EAET and RT. Social variables were not thoroughly assessed in
this study, yet based on the strong moderation effect of social constraints on outcomes, social
variables may yield further insight into which treatments benefit which patients, and should be
examined in future research. For example, individuals with more social contacts or perceived
higher-quality social support may benefit more from EAET compared to RT because of their
possible familiarity and comfort with emotional disclosure and expression. More research is also
needed to clarify the effects of certain key moderators, such as social constraints, on treatment
outcomes in IBS and other chronic pain populations. Future research should also examine the
effect of trauma, social constraints, ambivalence over emotional expression, and other
psychological variables on treatment outcomes in other pain populations, such as fibromyalgia,
chronic pelvic pain, or chronic headaches.
Additional studies should examine what mechanisms are at play in the effectiveness of
treatments for IBS. Understanding what techniques or processes (mediators) in EAET or RT affect
outcomes will help us to more easily identify which types of patients fit more clearly into what
types of processes. Additionally, further research should clarify why the moderator variables in
this study moderate effects of treatment on outcomes, and particularly moderate the effects of RT
on outcomes. The present study proposed some hypotheses that could be explored in future
studies—for example, that individuals with high social constraints, ambivalence over emotional
expression, and alexithymia benefit more from RT because of a common reluctance or difficulty
with engaging in and expression emotions, thus making RT more attractive and effective. Better
understanding the processes underlying these moderation effects will allow researchers to hone
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measurement in their studies and will help clinicians to identify best treatment approaches for
different individuals based on important baseline factors.
Implications
The findings from this study indicate that relaxation training may be more effective for
certain types of people, whereas EAET may be more helpful across the board. Although both
interventions (RT and EAET) appeared to generally result in improved health outcomes at 1- and
12-week follow-up, it seems that RT was especially helpful for certain individuals, particularly
those who are high in ambivalence over emotional expression and social constraints. This may
indicate that EAET is more helpful to a greater number of patients with IBS, whereas RT is
differentially helpful for certain groups. The commonality here may be anxiety, suggesting that
perhaps more anxious IBS patients disproportionately benefit from RT compared to their less
anxious counterparts. Or, it is possible that many of the moderators tested in this study (i.e.,
ambivalence, social constraints, and alexithymia) share a common underlying construct of lack of
readiness for or fear of emotional work. Although one could speculate that individuals with a fear
of engaging in emotions would quite benefit from an emotion-related intervention, this study
indicates that, in fact, these individuals do better with an intervention such as RT. This supports
the notion that fitting interventions to individuals’ current strengths and preferences may yield best
possible outcomes.

43
APPENDIX
TABLES & FIGURES
Table 1
Sample and Treatment Condition Demographic Data

Full Sample
(n = 106)

EAET
(n = 36)

RT
(n = 36)

TAU
(n = 34)

F/χ²
Value

p -value

M (SD)

36.14 (16.42)

40.36 (17.89)

34.11 (15.22)

33.82 (15.58)

1.83
0.02

.17
.99

n (%)
n (%)

21 (19.8)
85 (80.2)

7 (19.4)
29 (80.6)

7 (19.4)
29 (80.6)

7 (20.6)
27 (79.4)
0.73

.70

n (%)

69 (65.1)

22 (61.1)

23 (63.9)

24 (70.6)

n (%)

24 (22.6)

7 (19.4)

9 (25.0)

8 (23.5)

n (%)

4 (3.8)

2 (5.6)

0 (0)

2 (5.9)

n (%)

3 (2.8)

2 (5.6)

1 (2.8)

0 (0)

n (%)

2 (1.9)

2 (5.6)

0 (0)

0 (0)

n (%)

4 (3.8)

1 (2.8)

3 (8.3)

0 (0)

Marital
n (%)
4.32
Status
Married
n (%)
29 (27.4)
15(41.7)
7 (19.4)
7 (20.6)
Living with
n (%)
5 (4.7)
0 (0)
0 (0)
5 (14.7)
Partner
Divorced
n (%)
8 (7.5)
3(8.3)
2 (5.6)
3 (8.8)
Separated
n (%)
2 (1.9)
0 (0)
2 (5.6)
0 (0)
Widowed
n (%)
1 (0.9)
1(2.8)
0 (0)
0 (0)
Never
n (%)
61 (57.5)
17(47.2)
25 (69.4)
19 (55.9)
Married
Duration of
M (SD)
22.90 (12.84)
23.47 (12.83)
23.58 (12.78)
21.57 (13.21)
0.26
Symptoms
Note. All tests were 2-tailed. M = mean; SD = standard deviation;
Chi-square analysis for ethnicity was analyzed comparing only European American to Other (all nonEuropean Americans), due to the small numbers of non-European Americans in the dataset.
Chi-square analysis for marital status compared only Partner (married or living together with a significant
other) to Other (single, separated, divorced, widowed), due to the small numbers of non-partnered
individuals in the dataset.

.12

Age (years)
Gender
Male
Female
Ethnicity
European
American
African
American
Middle
Eastern
South Asian
East Asian
Other

.77
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Table 2
Comparison of Group Means and Adjusted Means on Outcome Measures at 4-week and 12-week Followups

Outcome
Measure
Symptom
Severity

Quality of
Life (Poor)

Time Point

Emotional
Awareness
and
Expression
Training
(n = 36)

Relaxation
Training
(n = 36)

Baseline M (SD)
4-week M (SD)
12-week M (SD)
4-wk Adj. M (SE)
12-wk Adj. M (SE)

5.46(1.76)
3.74(1.81)
3.56(2.27)
3.67(0.26)a
3.48(0.32)a

5.24(1.50)
4.13(1.46)
3.77(2.0)
4.17(0.26)ab
3.82(0.32)ab

Control
Group
(n = 34)

5.26(1.66)
4.83(1.91)
4.55(2.22)
4.86(0.27)b
4.59(0.33)b

Fvalue

p–
value

0.21

.82

5.18
3.00

.007
.054

Baseline M (SD)
2.41(0.57)
2.65(0.80)
2.43(0.81)
1.23
.30
4-week M (SD)
2.05(0.53)
2.34(0.73)
2.50(0.83)
12-week M (SD)
1.94(0.58)
2.14(0.78)
2.37(0.76)
a
a
4-wk Adj. M (SE)
2.12(0.07)
2.22(0.07)
2.55(0.07)b 9.86
<.001
a
a
12-wk Adj. M (SE)
2.00(0.10)
2.06(0.10)
2.39(0.10)b 4.41
.02
Anxiety
Baseline M (SD)
0.97(0.76)
0.97(0.76)
1.09(0.83)
0.47
.63
4-week M (SD)
0.68(0.72)
0.62(0.67)
1.20(0.91)
12-wk M (SD)
0.78(0.93)
0.56(0.61)
1.01(0.86)
4-wk Adj. M (SE)
0.73(0.11)a
0.62(0.11)a
1.14(0.11)b 6.50
.002
ab
a
b
12-wk Adj. M (SE)
0.83(0.11)
0.56(0.11)
0.95(0.12)
3.02
.053
Depression
Baseline M (SD)
0.61(0.63)
0.93(0.87)
1.02(0.91)
2.54
.08
4-week M (SD)
0.64(0.70)
0.60(0.74)
1.22(1.17)
12-week M (SD)
0.56(0.70)
0.55(0.70)
0.95(1.07)
4-wk Adj. M (SE)
0.84(0.10)b
0.53(0.10)a
1.09(0.11)b
7.13
.001
12-wk Adj. M (SE)
0.74(0.10)ab
0.49(0.10)a
0.83(0.10)b 2.94
.057
Hostility
Baseline M (SD)
0.69(0.67)
0.79(0.60)
0.85(0.78)
0.48
.62
4-week M (SD)
0.54(0.67)
0.63(0.52)
0.92(0.93)
12-week M (SD)
0.56(0.79)
0.50(0.46)
0.70(0.83)
4-wk Adj. M (SE)
0.60(0.09)a
0.62(0.09)ab
0.87(0.09)b 2.62
.08
12-wk Adj. M (SE)
0.61(0.09)
0.49(0.09)
0.65(0.09)
0.86
.43
Note: Note. All tests were 2-tailed. M = mean; SD = standard deviation;
Adjusted means with different superscripts differ significantly according to Fisher’s LSD post-hoc tests
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Table 3
Means, Standard Deviations, and Bivariate Correlations for Potential Moderator Measures (N =
106)
Correlations

1. Trauma

1

2

3

4

5

6

--

.24*

.38**

.37**

.17

-.18

--

.41**

.44**

.60**

-.40**

--

.44**

.24*

-.21*

--

.33**

-.13

--

-.61**

2. Ambivalence over Emotional
Expression
3. General Social Constraints
4. Impact of Events
5. Toronto Alexithymia Scale
6. Emotional Approach Coping

--

Mean

8.5

3.08

35.02

4.20

50.52

2.55

Standard Deviation

5.47

0.81

9.88

2.22

12.25

0.67

Range
p < .05; **p < .01

0-23

1.1-4.9

15-55

0-11.3

26-78

1-4

*
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Table 4
Descriptive Data for Outcome Variables
Outcome (Change scores)
Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

Time from N
baseline
4-week
105

SD

Min

Max

-.48

1.45

-4.5

4.95

12-week

106

.02

1.35

-3.18

5.64

4-week

106

-1.10

1.81

-6.6

3.80

12-week

106

-.27

1.58

-5.00

5.40

4-week

106

-.21

.49

-1.71

1.06

12-week

106

-.36

.70

-2.24

1.38

4-week

106

-.04

.66

-2.33

2.00

12-week

106

-.13

.49

-2.17

2.00

4-week

106

-.16

.75

-2.50

1.83

12-week

106

-.05

.56

-2.17

1.67

106

-.10

.89

-3.00

2.50

12-week

106

-.21

.96

-3.42

2.75

4-week

106

4.62

1.31

1

1

12-week

106

4.63

1.48

7

7

BSI-Interpersonal Sensitivity 4-week

Global Change

M
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Table 5
Correlations between Trauma and Changes in Outcome Measures for each of the Three
Treatment Conditions

Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

4-week

EAET
N = 37
0.06

RT
N = 36
0.12

WLC
N = 33
0.27

12-week

-0.16

-0.05

0.12

4-week

-0.10

-0.11

0.10

12-week

0.009

-0.002

-0.07

4-week

0.00

0.11

0.13

12-week

-0.01

-0.03

0.03

4-week

0.14

-0.11

0.22

12-week

0.13

-0.02

0.06

4-week

-0.01

0.26

0.19

12-week

0.26a

-0.21b

0.27a

-0.03

0.07

0.15

12-week

0.04

0.02

0.20

4-week

-0.15

0.04

-0.21

12-week

-0.13

-0.01

-0.16

BSI-Interpersonal Sensitivity 4-week

Global Change

*p < .05; **p < .01; ***p < .001
Note: See text for which conditions differ from each other.
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Table 6
Correlations between Ambivalence over Emotional Expression and Changes in Outcome
Measures for each of the Three Treatment Conditions

Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

4-week

EAET
N = 37
0.06

RT
N = 36
-.37*

WLC
N = 33
0.05

12-week

-0.06

0.00

-0.01

4-week

-0.18

-0.20

-0.01

12-week

0.01

-0.08

-0.05

4-week

-0.12

-0.36*

-0.21

12-week

-0.06

-0.11

-0.26

4-week

-0.12

-0.35*

0.08

12-week

0.08

-0.12

-0.18

4-week

-0.14

-0.17

-0.23

12-week

0.23

-0.20

-0.12

-0.35

-0.37

0.07

12-week

-0.13

-0.35

0.02

4-week

0.20

-0.01

0.22

12-week

0.06

-0.05

0.20

BSI-Interpersonal Sensitivity 4-week

Global Change

*p < .05; **p < .01; ***p < .001
Note: See text for which conditions differ from each other.
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Table 7
Correlations between General Social Constraints and Changes in Outcome Measures for each of
the Three Treatment Conditions

Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

4-week

EAET
N = 37
-0.05

RT
N = 36
-0.10

WLC
N = 33
.40*

12-week

0.07

0.06

0.16

4-week

-0.01

-.36*

.36*

12-week

0.07

0.06

-0.18

4-week

-0.22

-0.37*

0.28

12-week

-0.22

-0.30

0.08

4-week

-0.06

-0.23

0.07

12-week

0.01

-0.11

0.08

4-week

-0.21

0.16

-0.18

12-week

0.20

-0.42*

0.41*

-0.30

-0.10

-0.01

12-week

0.03

-0.25

0.18

4-week

0.20

0.09

-0.16

12-week

-0.04

-0.05

-0.24

BSI-Interpersonal Sensitivity 4-week

Global Change

*p < .05; **p < .01; ***p < .001
Note: See text for which conditions differ from each other.
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Table 8
Correlations between Impact of Events and Changes in Outcome Measures for each of the Three
Treatment Conditions

Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

4-week

EAET
N = 37
-0.20

RT
N = 36
-0.19

WLC
N = 33
0.33

12-week

0.22

0.33

0.28

4-week

-0.08

-0.01

0.16

12-week

0.03

0.24

0.15

4-week

-0.25

-0.18

0.24

12-week

-0.16

0.19

0.08

4-week

-0.10

-0.10

0.10

12-week

0.08

-0.20

0.08

4-week

-0.29

-0.13

0.08

12-week

-0.02

-0.16

0.06

-0.30

-0.10

0.20

12-week

0.01

-0.18

0.27

4-week

0.23

0.14

0.03

12-week

-0.03

-0.15

-0.25

BSI-Interpersonal Sensitivity 4-week

Global Change

*p < .05; **p < .01; ***p < .001
Note: See text for which conditions differ from each other.
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Table 9
Correlations between Emotional Approach Coping and Changes in Outcome Measures for each
of the Three Treatment Conditions

Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

4-week

EAET
N = 37
-0.22

RT
N = 36
-0.24

WLC
N = 33
0.12

12-week

0.00

-0.11

0.11

4-week

-0.04

0.05

-0.27

12-week

0.16

-0.05

0.10

4-week

0.01

-0.11

0.16

12-week

0.04

0.02

0.26

4-week

0.12

0.32

0.02

12-week

-0.15

-0.34*

0.27

4-week

0.08

-0.10

0.08

12-week

-0.02

-0.10

0.07

0.17

0.10

-0.01

12-week

0.10

-0.07

-0.03

4-week

-0.27

0.23

-0.17

12-week

-0.08

0.10

0.14

BSI-Interpersonal Sensitivity 4-week

Global Change

*p < .05; **p < .01; ***p < .001
Note: See text for which conditions differ from each other.
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Table 10
Correlations between Alexithymia and Changes in Outcome Measures for each of the Three
Treatment Conditions

Total Pain

IBS-SSS

IBS-QOL

BSI-Depression

BSI-Anxiety

4-week

EAET
N = 37
0.12

RT
N = 36
0.09

WLC
N = 33
-0.14

12-week

0.23

0.03

0.03

4-week

-0.03

-0.01

0.02

12-week

0.06

0.05

-0.03

4-week

0.04

-0.03

-0.14

12-week

0.17

-0.01

-0.14

4-week

-0.23

-0.21

0.07

12-week

0.18

0.04

-0.23

4-week

-0.12

0.08

-0.16

12-week

-0.02

-0.12

-0.18

-0.33

-0.07

0.12

12-week

-0.29

-0.12

0.05

4-week

0.23

-0.28

0.08

12-week

0.03

-0.29

0.12

BSI-Interpersonal Sensitivity 4-week

Global Change

*p < .05; **p < .01; ***p < .001
Note: See text for which conditions differ from each other.
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Figure 1. Trauma as a moderator of anxiety at 12-week follow-up.
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Figure 2. Ambivalence over emotional expression as a moderator of depression at 4-week
follow-up.
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Figure 3. Ambivalence over emotional expression as a moderator of interpersonal sensitivity at
4-week follow-up.
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Figure 4. Ambivalence over emotional expression as a moderator of interpersonal sensitivity at
12-week follow-up.
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Figure 5. Ambivalence over emotional expression as a moderator of McGill total pain at 4-week
follow-up.
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Figure 6. Ambivalence over emotional expression as a moderator of anxiety at 12-week followup.
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Figure 7. Social constraints as a moderator of anxiety at 12-week follow-up.
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Figure 8. Social constraints as a moderator of IBS symptom severity at 4-week follow-up.
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Figure 9. Social constraints as a moderator of IBS quality of life at 4-week follow-up.
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Figure 10. Social constraints as a moderator of interpersonal sensitivity at 12-week follow-up.
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Figure 11. Impact of events as a moderator of McGill total pain at 4-week follow-up.
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Figure 12. Impact of events as a moderator of IBS quality of life at 4-week follow-up.
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Figure 13. Impact of events as a moderator of interpersonal sensitivity at 4-week follow-up.
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Figure 14. Emotional approach coping as a moderator of depression at 12-week follow-up.
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Figure 15. Emotional approach coping as a moderator of global change in IBS symptoms at 4week follow-up.
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Figure 16. Alexithymia as a moderator of global change in IBS symptoms at 4-week follow-up.
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ABSTRACT
AMBIVALENCE OVER EMOTIONAL EXPRESSION, SOCIAL CONSTRAINTS, AND
TRAUMA AS MODERATORS OF EMOTIONAL AWARENESS AND EXPRESSION
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by
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Irritable bowel syndrome (IBS) is a central sensitization gastrointestinal disorder that
affects 10-15% of the population. Psychosocial factors, including stress, social support, emotional
processes, and trauma, have been shown to play a role in the development of IBS and the severity
of symptoms. Effect sizes for psychological treatments are modest, indicating individual
differences in effectiveness. A subset of patients with IBS may benefit from Emotional Awareness
and Expression Training (EAET), a novel intervention that encourages the awareness and
expression of emotions. In this study, 106 participants with IBS were randomized into one of two
interventions—Relaxation Training or EAET—or a Waitlist Control group. Participants
completed measures of IBS symptom severity and quality of life, emotional processes, and trauma.
Moderator analyses were used to test whether individuals with more ambivalence over emotional
expression, greater perceived social constraints, and more traumatic experiences are more likely
to benefit from EAET than those with lower scores on these constructs. Results indicated that
overall, the hypothesized and exploratory moderators moderate the effects of treatment group on
health outcomes for RT compared to WLC, but not EAET compared to RT or WLC as
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hypothesized. Specifically, although both interventions (EAET and RT) appeared to result in
improved health outcomes at 1- and 12-week follow-up (Thakur et al., 2016), it seems that RT was
especially helpful for certain individuals, which may indicate that EAET is more helpful to a
greater number of patients with IBS while RT is differentially helpful for certain groups.
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